Apoptosis is now widely recognized as a physiological form of cell death driven by a programme of biochemical events. In vivo, the usual fate for cells being deleted by apoptosis is swift recognition, uptake and degradation by phagocytes in a manner preventing uncontrolled leakage of noxious contents from dying cells. In many cases, this clearance task is done by neighbouring cells of the same lineage; a good example is the ingestion of apoptotic renal tubular cells by adjacent healthy epithelial cells [ 11. However, where the load of apoptotic cells is great, as in the thymus, lymph node, bone marrow and at sites of inflammation, large numbers of apoptotic cells can be cleared efficiently by professional phagocytes of the macrophage series. Until recently, very little was known of the molecular mechanisms mediating phagocyte uptake of apoptotic cells, but within the last few years there has been rapid growth in the number of molecules implicated in Abbreviations used: M4, macrophage; TSP, thrombospondin; PS, phosphatidylserine. this process (Tables 1 and 2 ). T h e purpose of this article is to summarize the evidence that implicates these cell-surface molecules in phagocyte recognition of 'apoptotic self' and to make [16] , which led to rapid and widespread hepatocyte apoptosis. Presumably because this unphysiologically massive load of apoptotic cells exceeded the local clearance capacity, apoptotic hepatocytes eventually disintegrated, releasing noxious contents that in turn induced severe liver injury [ 161. Indeed, undesirable leakage of contents from cells undergoing apoptosis may have deleterious consequences beyond inciting or exacerbating local tissue injury and inflammatory responses. In particular, components of apoptotic cells such as (o1igo)nucleosomes may stimulate the immune system [17] , and it appears likely that failed clearance of apoptotic cells may contribute to the perpetuation of autoimmune responses in systemic lupus erythematosus and related disorders. This is because important nuclear autoantigens can, during programmed cell death, undergo preferential redistribution into surface blebs [18] . These may detach from dying cells as membrane-bound 'apoptotic bodies', which are normally recognized by phagocytes; should this fail then subsequent disintegration would release packets of autoantigen. These observations are important because there is growing interest in designing new therapeutic agents which trigger apoptosis in 'dangerous' cells, such as tumour cells or autoreactive lymphocytes. Unless local phagocytic mechanisms are available to cope with large increases in load of apoptotic cells, such putative treatments might incite both severe local tissue injury and autoimmunity.
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There are a number of approaches towards characterizing mechanisms by which phagocytes recognize apoptotic cells. Important insights into the molecular basis of programmed cell death have come from genetic studies of the nematode Caenorhabditis elegans, which is subject to mutations that not only lead to abnormal numbers of apoptosis-like developmental cell deaths, but also result in failed uptake of dying cells [19] . Indeed, up to seven genes have been implicated in this process, but their relevance may be limited to 'semi-professional' phagocytic clearance of apoptotic cells, since C. elegans does not have specialized phagocytes. Nevertheless, there are exciting preliminary data to suggest that human homologues of such genes could be involved in macrophage recognition of apoptotic cells, and that comparable genetic approaches may be useful in Drosophila, which does have macrophage-like cells (see below). However, to date, most of our knowledge has come from cell biological approaches using in vitro models of phagocyte recognition of apoptotic cells. These have achieved partial characterization of three major recognition mechanisms, which will now be described in chronological order of discovery.
There is good evidence to suggest that apoptotic cells preferentially display cell-surface sugar residues that are recognized by phagocyte lectins, albeit poorly characterized as yet. Seminal studies from Wyllie's laboratory implicated macrophage lectins, selective for N-acetyl glucosamine, N-acetyl galactosamine and galactose, in low-temperature binding of apoptotic rodent thymocytes by .resident peritoneal macrophages [Z]. By contrast with other macrophage populations, resident macrophages are not efficient phagocytes for apoptotic cells, and it seems likely that lectin recognition of cell-surface sugar changes consequent upon apoptosis may be particularly important in uptake of dying cells by semi-professional phagocytes. In particular, Dini's work has suggested that such mechanisms may be important in uptake of apoptotic cells by liver cells, including endothelial cells [ 31, and that pro-inflammatory stimuli such as interleukin-1 may up-regulate this mechanism. Furthermore, there is evidence that a lectin with specificity for mannose/fucose may be involved in uptake of apoptotic neutrophils by cultured fibroblasts [6] .
Human monocyte-derived macrophages Volume 24 ( M~s ) , which are able rapidly to take up large numbers of apoptotic cells, employ a different recognition mechanism involving two M 4 cellsurface molecules, the x,lj3 vitronectin receptor integrin heterodimer and the monomeric adhesion receptor CD36 [4, 7] . These receptors co-operatively bind a soluble adhesive glycoprotein synthesized by M 4 and other cells, thrombospondin (TSP)-1, which in turn 'bridges' the M 4 to as yet uncharacterized anionic, protease-resistant sites on apoptotic cells [7] . This x(,lj3ITSPICD36 mechanism has been implicated in M 4 uptake of apoptotic neutrophils [7] , eosinophils [20] and lymphocytes [21] . Although initially characterized in a series of experiments relying on blockade of M 4 uptake of apoptotic cells by monoclonal antibodies, strong support for the importance of the r,/131TSPICD36 mechanism came from experiments showing that transfection of 'amateur' phagocytes with cDNA for CD36 specifically conferred capacity, in some cases to 'near-professional' levels, for phagocytosis of apoptotic cells by a mechanism involving both a,P3 and TSP [8] . Furthermore, although experiments are not yet complete, it appears very likely that murine M 4 s derived from in vitro culture of bone-marrow cells with colony-stimulating factor-1 employ an identical recognition mechanism [ S ] . However, there are also data to suggest that x , P 3 may co-operate with phagocyte receptors other than CD36 to achieve uptake of apoptotic cells by semi-professional phagocytes. In fibroblasts, x,P3 co-operates with the mannose/ fucose-specific lectin referred to above, whereas in glomerular mesangial cells r,P3 may co-operate with TSP receptors other than CD36 (J. Hughes, Y. Liu, Y. Ren and J. Savill, unpub- lished work). Nevertheless, the data generally emphasize that the a,/13/TSP/CD36 mechanism is intrinsically a 'high-capacity' clearance system suitable for the demands imposed on professional phagocytes by large loads of apoptotic cells, and in vitro data show that this mechanism can be potentiated still further by a range of proinflammatory cytokines [23] .
The third major mechanism for recognition of apoptotic cells was discovered during studies by Fadok, Henson and colleagues of murine inflammatory macrophages obtained by stimulating the peritoneum with thioglycollate [5, 10] . They showed, on the basis of enhanced merocyanine 540 binding and increased derivatization of aminophospholipids with fluorescamine, that apoptotic cells lose the normal membrane asymmetry by which the anionic phospholipid phosphatidylserine (PS) is selectively localized to the inner membrane leaflet. Preferential exposure of PS on the surface of apoptotic cells was shown by increased PS-dependent pro-coagulant activity. Subsequently, selective binding of labelled annexin V has been shown to be a useful and specific tool for detection of PS exposed on the surface of apoptotic cells [24, 25] , and Verhoven and colleagues have evidence that PS exposure results from co-ordinated down-regulation of an ATP-dependent aminophospholipid translocase and activation of a non-specific lipid scramblase [26] . Fadok and colleagues used PS analogues to inhibit in vitro uptake of apoptotic cells of various lineages, showing that as yet uncharacterized stereospecific PS receptors were employed by murine inflammatory macrophages and human THP-1 cells stimulated with phorbol ester, whereas murine bone-marrow-derived M 4 s employed sn r,lj3/TSPICD36-dependent mechanism to ingest apoptotic cells [S] . Interestingly, the latter could be 'switched' to a PSdependent mechanism by uptake of digestible P-glucan particles via an autocrine mechanism involving transforming growth factor-lj [27] . T h e significance of this observation is not yet clear, but it argues strongly that there are important reasons why particular phagocyte populations should employ one recognition mechanism rather ' than another.
This theme of preferential usage of a single dominant recognition mechanism by a particular phagocyte population gains further support from recent data implicating still more molecules in recognition of apoptotic cells in vitro. Thus However, a second theme to emerge from in vztm studies is that apparently discrete recognition mechanisms may in fact co-operate to achieve phagocytosis. The co-operation of a,b3 with CD36 to achieve high-efficiency phagocytosis or with lectins to achieve semi-professional phagocytosis has received attention above. It has been tempting to speculate that, by analogy with extravasation of leucocytes from capillaries at inflamed sites, there may be classes of molecules involved in initial 'tethering' of apoptotic cells, which then 'hand on' apoptotic cells to tight-binding phagocytic receptors and associated signalling molecules that drive the phagocytic process. The recognition assay employed by Flora and Gregory involved both tethering and phagocytosis [ll] , and their data are consistent with the idea that the M$ 61D3 antigen may be involved in initial loose binding before apoptotic cells are engaged by the a,,!?dTSP/CD36 mechanism, or by other phagocytic mechanisms yet to be defined. Perhaps Luciani and Chimini's elegant demonstration of involvement of the mammalian ATP-binding cassette transporter ABCl in uptake of apoptotic cells [12] indicates that this molecule plays a role in driving later stages of the phagocytic process, since the ATPbinding domains of this molecule, one of an evolutionarily conserved family devoted to translocation of substrates across membranes, are in the cytoplasm. Indeed, this group's data also argue that the C. elegans 'cell corpse clearance' genes such as ced-7 may yet prove important in mammals, since a structural homologue of ABCl was identified in the C. elegans genome and maps closely to the ced-7 locus.
Lastly, there is also growing evidence to suggest that dying cells, during the course of apoptosis, become recognizable in temporal sequence to a hierarchy of recognition mechanisms that 'back up' one another, and are coupled to phagocyte responses designed to modulate the cellular composition of tissues so as to cope with clearance of dying cells. M$s taking up apoptotic neutrophils or eosinophils by the a,BdTSPICD36 mechanism do not release a range of pro-inflammatory mediators [29] . Although it is not known whether PS receptors are also uncoupled from pro-inflammatory responses, these data strongly suggest that clearance of 'early' apoptotic cells can be achieved without inciting inflammation, in keeping with copious in vivo observations of cell clearance by apoptosis in the absence of inflammation. However, should 'early' apoptotic cells elude clearance, perhaps due to a deficiency of suitable phagocytes or undesirable presence of soluble inhibitors (such as fragments of fibronectin in the a,P31TSPICD36 scheme), there is now preliminary evidence that just before disintegration their surface may change again so that they engage a different recognition mechanism that is coupled to pro-inflammatory responses [ 191. Teleologically, the purpose of pro-inflammatory clearance of intact 'post-apoptotic' cells might be seen as calling in more phagocytes capable of ingesting early apoptotic cells.
T o conclude, having defined many molecules that may be involved in phagocytic clearance of apoptotic cells, we must go on to test hypotheses as to how these molecules interact. In dissecting possible sequential interactions at the phagocyte surface, or in defining a temporal hierarchy of recognition mechanisms engaged during the course of apoptosis, there will be a place for careful in vitro cell biology studies. However, to determine the in vivo importance of these molecules, and to define whether particular recognition mechanisms are indeed used for discrete clearance tasks, we will need to design in vzvo experiments. Perhaps 'redundancy' may frustrate studies of mice 'knocked out' for particular recognition molecules, but these experiments should be done. However, an important alternative approach may be to exploit the power of Dmsophila genetics, since this organism has M$-like cells and may use similar recognition mechanisms in uptake of apoptotic cells, the CD36-like molecule Croquemort being an interesting example [9] .
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